1. Home
  2. MXCT vs KIO Comparison

MXCT vs KIO Comparison

Compare MXCT & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • KIO
  • Stock Information
  • Founded
  • MXCT 1999
  • KIO 2011
  • Country
  • MXCT United States
  • KIO United States
  • Employees
  • MXCT N/A
  • KIO 2400
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KIO Investment Managers
  • Sector
  • MXCT Health Care
  • KIO Finance
  • Exchange
  • MXCT Nasdaq
  • KIO Nasdaq
  • Market Cap
  • MXCT 375.0M
  • KIO 356.1M
  • IPO Year
  • MXCT 2021
  • KIO N/A
  • Fundamental
  • Price
  • MXCT $4.11
  • KIO $13.10
  • Analyst Decision
  • MXCT Strong Buy
  • KIO
  • Analyst Count
  • MXCT 2
  • KIO 0
  • Target Price
  • MXCT $9.50
  • KIO N/A
  • AVG Volume (30 Days)
  • MXCT 558.7K
  • KIO 136.5K
  • Earning Date
  • MXCT 11-06-2024
  • KIO 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • KIO 10.82%
  • EPS Growth
  • MXCT N/A
  • KIO N/A
  • EPS
  • MXCT N/A
  • KIO N/A
  • Revenue
  • MXCT $45,599,000.00
  • KIO N/A
  • Revenue This Year
  • MXCT N/A
  • KIO N/A
  • Revenue Next Year
  • MXCT $21.27
  • KIO N/A
  • P/E Ratio
  • MXCT N/A
  • KIO N/A
  • Revenue Growth
  • MXCT 19.85
  • KIO N/A
  • 52 Week Low
  • MXCT $3.17
  • KIO $10.52
  • 52 Week High
  • MXCT $5.55
  • KIO $13.59
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 55.35
  • KIO 34.25
  • Support Level
  • MXCT $3.98
  • KIO $12.88
  • Resistance Level
  • MXCT $4.41
  • KIO $13.78
  • Average True Range (ATR)
  • MXCT 0.27
  • KIO 0.13
  • MACD
  • MXCT -0.00
  • KIO -0.03
  • Stochastic Oscillator
  • MXCT 54.64
  • KIO 24.44

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About KIO KKR Income Opportunities Fund

KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.

Share on Social Networks: